NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ: KROS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
Hence then, the article about shareholder alert pomerantz law firm investigates claims on behalf of investors of keros therapeutics inc kros was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. - KROS )
Also on site :
- Asia rolls out four-day weeks and work-from-home as emergency measures to solve a fuel crisis caused by Iran war
- Bruce Springsteen, Tom Waits and Others Remember Shane MacGowan With Tribute Album ‘20th Century Paddy’
- Iran war enters day 13: Missiles fly, tankers burn, oil prices soar; what’s happening in Middle East?